started · updated
NFL and NFLPA launch joint review of Jalen Hurts medical diagnosis
The NFL and the NFL Players Association (NFLPA) have initiated a joint investigation into the medical handling of Philadelphia Eagles quarterback Jalen Hurts’ blood clot diagnosis. The review follows an NFLPA call for an investigation after Hurts was diagnosed with deep vein thrombosis and bilateral pulmonary emboli, which will sideline him for the remainder of the season.
Reports indicate Hurts was initially diagnosed with a superficial blood clot in his calf following a game against the Los Angeles Rams. Despite this, he was medically cleared to play against the Jacksonville Jaguars in London on October 11. Subsequent testing revealed the clot had traveled to his lungs. While NFL Chief Medical Officer Dr. Allen Sills defended the Eagles’ medical staff as being “incredibly conservative” and “vigilant,” the league and the union are now working to determine the logistics of a formal review.
Internal tensions have emerged, with reports suggesting the NFL is “furious” with the Eagles regarding a perceived lack of transparency in their public statements. The investigation aims to examine the communication and medical protocols used during the period between the initial diagnosis and the player's placement on injured reserve.
Entities
Allen Sills · Jalen Hurts · NFL · NFL Players Association · Philadelphia Eagles